Presents Insights into Industry Trends, Major Products, Mergers & Acquisitions, and Other Collaborations or Partnerships
Biomarkers Market
Biomarkers Market
Dublin, Jan. 14, 2025 (GLOBE NEWSWIRE) — The “Biomarkers Markets and Technologies” report has been added to ResearchAndMarkets.com’s offering.
The Biomarkers Market was valued at USD 70.5 billion in 2024, and is expected to reach USD 130.2 billion by 2029, rising at a CAGR of 13.10%.
The scope of this report on the global market for biomarker technologies encompasses an analysis of the current landscape, including market size, growth trends and segmentation by product type, technology, therapeutic area and end user. The report breaks down the market into several product categories: instruments, consumables (such as reagents, kits and panels), services and software. It also segments the market by technology: genomics, proteomics, metabolomics, imaging and bioinformatics. It also examines the biomarker market across the therapeutic areas of cancer; cardiovascular, metabolic, infectious and neurodegenerative diseases; and autoimmune disorders. The end-user segments are academic institutions, pharmaceutical and biotechnology companies, clinical research organizations, hospitals and diagnostic centers.
By region, the analysis encompasses North America, Europe, Asia-Pacific, and the Rest of the World (RoW). The report also includes profiles of leading companies and highlights industry trends, major products, mergers and acquisitions, and other collaborations or partnerships.
The report includes:
34 data tables and 62 additional tables
An up-to-date overview of the global markets and technologies for biomarkers
Analysis of the global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
Evaluation of the size and revenue growth prospects, accompanied by a market share analysis by product type, technology, therapeutic area, end user, and region
Assessment of market dynamics such as drivers, restraints and opportunities
Coverage of major types of biomarkers and their use in clinical trial assessment, drug discovery and development, and therapeutics
Review of patents issued for biomarker technologies and deep dive of patent data by year, technology type, application, company, assignee and applicant country
A discussion on ESG challenges and practices in the industry
Assessment of the vendor landscape, including the market shares of key companies, their product portfolios and financial overviews
Information on recent mergers, acquisitions, expansions, collaborations, investments, divestments, product launches, and other strategic developments
Profiles of the leading companies, including F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Illumina Inc., Bio-Rad Laboratories Inc., and Agilent Technologies Inc.
Key Attributes
Report Attribute
Details
No. of Pages
165
Forecast Period
2024-2029
Estimated Market Value (USD) in 2024
$70.5 Billion
Forecasted Market Value (USD) by 2029
$130.2 Billion
Compound Annual Growth Rate
13.1%
Regions Covered
Global
Key Topics Covered
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Overview
Classification of Biomarkers
Examples of Biomarkers
Susceptibility/Risk Biomarkers
Diagnostic Biomarkers
Monitoring Biomarkers
Prognostic Biomarkers
Predictive Biomarkers
Pharmacodynamic (Response) Biomarkers
Safety Biomarkers
Surrogate Biomarkers/Endpoints
Discovery, Verification and Validation
Biomarker Qualification
Applications of Biomarkers
Diagnostics, Therapeutics and Disease Monitoring
Drug Discovery and Development
Clinical Trials
Chapter 3 Market Dynamics
Overview
Market Drivers
Rising Incidence of Diseases
Advances in Omics and Imaging Technologies
Market Restraints
High Development Costs
Requirement for Skilled Labor
Market Opportunities
Emerging Markets
Personalized Medicine
Chapter 4 Emerging Technologies and Developments
Overview
Emerging Technologies
Genomics
Proteomics
Metabolomics
Imaging
Bioinformatics
Clinical Trials
Clinical Trial Analysis, by Therapeutic Area
Clinical Trial Analysis, by Study Status
Clinical Trial Analysis, by Study Type
Patent Analysis
Chapter 5 Market Segmentation Analysis
Market Trends
Segmentation Breakdown
Biomarkers: Global Markets
Market Analysis by Product Type
Consumables
Instruments
Services
Software
Market Analysis by Technology
Proteomics
Genomics
Imaging
Bioinformatics
Metabolomics
Market Analysis by Therapeutic Area
Cancer
Cardiovascular and Metabolic Diseases
Neurodegenerative Diseases
Infectious Diseases
Autoimmune Diseases
Other Diseases
Market Analysis by End User
Hospitals and Diagnostic Labs
Academic and Research Institutes
Pharmaceutical and Biotech Companies
Contract Research Organizations
Geographic Breakdown
Market Analysis by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 6 Competitive Intelligence
Chapter 7 Sustainability in Biomarkers Technologies and Global Markets: An ESG Perspective
Chapter 8 Appendix
Methodology
Sources
Abbreviations
Major companies profiled in this Biomarkers market report include:
Abbott
Agilent Technologies Inc.
Bayer AG
BD
Bio-Rad Laboratories Inc.
Bruker
Danaher Corp.
F. Hoffmann-La Roche Ltd.
Fujifilm Holdings Corp.
GE Healthcare
Illumina Inc.
Jeol Ltd.
Koninklijke Philips N.V.
Promega Corp.
Qiagen
Revvity
Shimadzu Corp.
Siemens Healthineers AG
Thermo Fisher Scientific Inc.
For more information about this report visit
About ResearchAndMarkets.com ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
